Cognition Therapeutics, Inc.
CGTX
$1.20
$0.021.70%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 36.81M | 39.33M | 10.74M | 16.43M | 25.01M |
| Total Receivables | 9.92M | 1.90M | 6.29M | 4.78M | 2.69M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.07M | 1.16M | 1.21M | 1.66M | 1.86M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 190.00K | 489.00K | 814.00K | -- | -- |
| Total Current Assets | 47.99M | 42.88M | 19.05M | 22.87M | 29.56M |
|
|
|||||
| Total Current Assets | 47.99M | 42.88M | 19.05M | 22.87M | 29.56M |
| Net Property, Plant & Equipment | 399.00K | 512.00K | 573.00K | 634.00K | 679.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 48.39M | 43.40M | 19.62M | 23.50M | 30.23M |
|
|
|||||
| Total Accounts Payable | 1.12M | 827.00K | 771.00K | 1.82M | 1.98M |
| Total Accrued Expenses | 12.00M | 3.92M | 9.37M | 7.71M | 7.62M |
| Short-term Debt | 307.00K | -- | 41.00K | 161.00K | 279.00K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 136.00K | 168.00K | 198.00K | 194.00K | 193.00K |
| Total Finance Division Other Current Liabilities | 367.00K | 1.74M | 1.98M | 1.07M | 1.07M |
| Total Other Current Liabilities | 367.00K | 1.74M | 1.98M | 1.07M | 1.07M |
| Total Current Liabilities | 13.92M | 6.65M | 12.36M | 10.95M | 11.14M |
|
|
|||||
| Total Current Liabilities | 13.92M | 6.65M | 12.36M | 10.95M | 11.14M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 307.00K | -- | 41.00K | 161.00K | 279.00K |
| Capital Leases | 195.00K | 212.00K | 229.00K | 280.00K | 342.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 14.12M | 6.87M | 12.59M | 11.23M | 11.48M |
|
|
|||||
| Common Stock & APIC | 232.92M | 231.83M | 197.40M | 195.91M | 193.91M |
| Retained Earnings | -198.65M | -195.30M | -190.37M | -183.64M | -175.16M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 34.27M | 36.53M | 7.03M | 12.27M | 18.75M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 34.27M | 36.53M | 7.03M | 12.27M | 18.75M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 34.27M | 36.53M | 7.03M | 12.27M | 18.75M |
|
|
|||||